Start Submission

Reading: Hypertension in Canada: Past, Present, and Future


A- A+
Alt. Display

State of the Art Review

Hypertension in Canada: Past, Present, and Future


Ernesto L. Schiffrin ,

Department of Medicine, Jewish General Hospital, McGill University, Montreal, Quebec, Canada
About Ernesto L.
X close

Norman R.C. Campbell,

Libin Cardiovascular Institute of Alberta, University of Calgary, Alberta, Canada
About Norman R.C.
X close

Ross D. Feldman,

Discipline of Medicine, Memorial University Health Sciences Centre, St. John’s, Newfoundland, Canada
About Ross D.
X close

Janusz Kaczorowski,

Department of Family and Emergency Medicine and CRCHUM, Université de Montréal, Montreal, Quebec, Canada
About Janusz
X close

Richard Lewanczuk,

Division of Endocrinology, Department of Medicine, University of Alberta, Primary Health Care, Alberta Health Services, Alberta, Canada
About Richard
X close

Raj Padwal,

Department of Medicine, University of Alberta, Alberta, Canada
About Raj
X close

Sheldon W. Tobe

Division of Nephrology, Department of Medicine, University of Toronto Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada; Northern Ontario School of Medicine, Ontario, Canada
About Sheldon W.
X close


Canada has an extremely successful hypertension detection and treatment program. The aim of this review was to highlight the historic and current infrastructure and initiatives that have led to this success, and the outlook moving forward into the future. We discuss the evolution of hypertension awareness and control in Canada; contributions made by organizations such as the Canadian Hypertension Society, Blood Pressure Canada, and the Canadian Hypertension Education Program; the amalgamation of these organizations into Hypertension Canada; and the impact that Hypertension Canada has had on hypertension care in Canada. The important contribution that public policy and advocacy can have on prevention and control of blood pressure in Canada is described. We also highlight the importance of population-based strategies, health care access and organization, and accurate blood pressure measurement (including ambulatory, home, and automated office modalities) in optimizing hypertension prevention and management. We end by discussing how Hypertension Canada will move forward in the near and longer term to address the unmet residual risk attributable to hypertension and associated cardiovascular risk factors. Hypertension Canada will continue to strive to enhance hypertension prevention and control rates, thereby improving the quality of life and cardiovascular outcomes of Canadians, while at the same time creating a hypertension care model that can be emulated across the world.
How to Cite: Schiffrin, E.L., Campbell, N.R.C., Feldman, R.D., Kaczorowski, J., Lewanczuk, R., Padwal, R. and Tobe, S.W., 2016. Hypertension in Canada: Past, Present, and Future. Annals of Global Health, 82(2), pp.288–299. DOI:
Published on 29 Jun 2016.
Peer Reviewed


  • PDF (EN)